sinc
dawn
time
least
dawn
recombin
dna
technolog
mani
today
scientist
thing
investig
clone
express
heterolog
protein
varieti
differ
cell
varieti
differ
reason
rang
cell
biolog
studi
look
proteinprotein
interact
posttransl
modif
regul
laboratoryscal
product
support
biochem
biophys
structur
studi
larg
scale
product
potenti
biotherapeut
parallel
fusiontag
technolog
grownup
facilit
microscal
purif
pulldown
protein
visual
epitop
tag
enhanc
express
solubl
protein
partner
eg
gst
mbp
trx
sumo
gener
purif
eg
histag
streptag
flag
tm
tag
frequent
latter
two
goal
combin
singl
fusion
partner
review
examin
commonli
use
fusion
methodolog
perspect
ultim
use
tag
protein
commonli
use
fusion
partner
pulldown
structur
studi
product
activ
protein
largescal
purif
advantag
limit
review
meant
exhaust
approach
undoubtedli
reflect
experi
interest
author
sake
breviti
larg
ignor
epitop
tag
although
receiv
wide
use
cell
biolog
immunoprecipt
advanc
genom
proteom
bioinformat
last
thirti
year
dramat
increas
use
recombin
dna
way
studi
protein
interest
varieti
applic
combin
affin
tag
recombin
dna
techniqu
allow
identif
modif
product
isol
purif
protein
rang
host
system
includ
e
coli
yeast
plant
insect
mammalian
cell
line
howev
product
recombin
protein
routin
encount
problem
includ
format
inclus
bodi
incorrect
protein
conform
toxic
host
cell
low
protein
yield
issu
often
address
chang
express
host
fusion
protein
interest
poi
carrier
protein
fusion
tag
locat
either
cterminu
protein
interest
fusion
tag
improv
protein
solubl
achiev
nativ
protein
fold
increas
total
yield
improv
express
decreas
degrad
fusion
tag
may
use
tandem
affin
tag
marker
improv
detect
allow
protein
secret
achiev
greater
total
yield
sever
publish
review
affin
fusion
tag
past
sever
correspond
jame
e
strickler
lifesensor
inc
great
valley
parkway
malvern
pa
email
strickler
lifesensorscom
year
review
excel
job
describ
mani
tag
tag
remov
system
current
avail
difficult
determin
tag
best
candid
specif
applic
exampl
estim
eukaryot
protein
express
solubl
form
prokaryot
host
given
variabl
protein
structur
mani
tag
may
similar
issu
review
therefor
focus
tag
util
specif
protein
applic
includ
proteinprotein
interact
pulldown
assay
structur
determin
exampl
xray
crystallographi
control
mainten
protein
function
larg
scale
manufactur
list
mean
exhaust
hope
provid
insight
promin
tag
use
applic
protein
work
isol
instead
interact
complex
network
studi
one
protein
isol
protein
complex
sever
use
includ
purif
one
bind
partner
identif
unknown
bind
partner
protein
complex
immunoprecipit
coip
techniqu
antibodi
bound
known
target
protein
allow
protein
protein
bound
precipit
pulleddown
solut
analyz
effect
one
problem
techniqu
difficulti
gener
specif
antibodi
target
protein
solut
clone
dna
target
protein
express
vector
contain
fusion
tag
either
terminu
protein
depend
tag
either
affin
chromatographi
antibodi
use
captur
complex
use
affin
chromatographi
drastic
speed
process
protein
isol
identif
allow
purif
process
use
repeatedli
addit
system
use
increas
express
target
protein
beyond
endogen
level
potenti
allow
complet
pulldown
protein
complex
provid
greater
amount
specif
bound
protein
common
fusion
tag
use
pulldown
assay
glutathionestransferas
gst
kda
protein
parasit
helminth
schistosomajaponicum
gst
bind
high
affin
glutathion
use
fusion
tag
gst
increas
protein
yield
allow
effici
initi
translat
gst
use
wide
rang
cell
type
includ
e
coli
yeast
plant
insect
mammalian
cell
purif
gstprotein
fusion
bound
glutathion
immobil
solid
support
agaros
bead
magnet
particl
fusion
construct
elut
addit
mm
reduc
glutathion
target
associ
protein
analyz
standard
method
sdspage
western
blot
gst
use
nand
ctermin
tag
mani
commerci
avail
system
proteas
cleavag
site
encod
gst
target
protein
allow
remov
gst
purif
one
problem
occur
gstbase
pull
assay
solubl
bind
protein
specif
protein
either
highli
hydrophob
larger
kda
tend
form
insolubl
aggreg
inclus
bodi
tag
gst
render
inact
correct
deterg
triton
x
chap
often
use
purif
process
enhanc
solubl
fusion
complex
deterg
disrupt
biolog
activ
bind
protein
high
salt
buffer
also
use
encourag
solubl
anoth
issu
gst
propens
dimer
nativ
gst
exist
homodim
fuse
target
protein
also
oligomer
result
fusion
form
larg
complex
easili
elut
bound
glutathion
resin
strategi
prevent
dimer
includ
modif
salt
ph
addit
strong
reduc
agent
dithiothreitol
dtt
anoth
tactic
promot
elut
addit
extra
free
glutathion
switch
elut
agent
sbutylglutathion
higher
affin
gst
glutathion
case
insolubl
sever
solut
may
disrupt
function
tag
protein
research
suggest
gst
suitabl
pull
assay
protein
known
oligomer
common
gst
tag
use
pulldown
assay
technic
affin
tag
fuse
target
protein
work
wide
use
affin
tag
gener
come
littl
surpris
polyhistidin
tag
usual
hexahistidin
also
popular
pulldown
assay
although
tag
offer
increas
express
solubl
level
small
kda
immunogenit
inact
dimer
like
gst
tag
may
attach
target
protein
either
cterminu
protein
function
tag
attach
purif
fusion
involv
immobil
metalaffin
chromatographi
imac
neg
charg
histidin
bind
posit
charg
metal
ion
commonli
ni
fusion
construct
elut
imidazol
gradient
either
stepwis
linear
one
disadvantag
imidazol
elut
observ
high
imidazol
concentr
found
remov
metal
ion
varieti
bell
et
al
protein
leav
inact
possibl
alter
natur
proteinprotein
interact
beyond
gst
number
addit
tag
use
pulldown
assay
includ
streptag
fragment
crystal
fc
fusion
although
seen
much
lower
overal
number
gener
good
qualiti
protein
structur
studi
nmr
spectroscopi
xray
crystallographi
cryoelectron
microscopi
place
stringent
demand
protein
product
approach
requir
multimilligram
quantiti
protein
high
puriti
product
techniqu
minim
use
deterg
chaotrop
reduc
agent
might
alter
final
structur
protein
prevent
format
good
qualiti
diffract
crystal
incorpor
fusion
tag
overcom
challeng
increas
yield
enhanc
fold
streamlin
purif
also
creat
new
obstacl
multidomain
fusion
protein
join
flexibl
linker
may
less
like
form
wellord
diffract
crystal
larg
nmr
studi
strategi
requir
tag
remov
introduc
challeng
includ
optim
cleavag
condit
ad
cost
proteas
tag
remov
failur
recov
solubl
structur
intact
protein
tag
remov
balanc
howev
advantag
use
fusion
tag
produc
protein
structur
studi
outweigh
disadvantag
fusion
tag
wide
adopt
method
choic
protein
product
structur
studi
protein
produc
crystal
express
fusion
construct
far
tag
common
fusion
partner
use
crystallograph
studi
tag
small
size
gener
interfer
crystal
util
nickel
affin
chromatographi
facilit
simpl
costeffect
purif
multimilligram
scale
tag
certain
disadvantag
howev
variabl
gluconoyl
e
coli
lead
heterogen
conduc
crystal
format
tag
clearli
effect
structur
studi
structur
genom
center
estim
prokaryot
protein
insolubl
express
e
coli
histag
addit
studi
suggest
number
higher
eukaryot
protein
mani
larg
fusion
tag
maltos
bind
protein
mbp
gst
thioredoxin
small
ubiquitinlik
modifi
sumo
enhanc
solubl
either
directli
combin
small
affin
tag
simplifi
purif
therefor
express
target
protein
fusion
tag
often
use
rescu
strategi
difficult
express
protein
cf
case
tag
proteolyt
remov
prior
crystal
engin
endoproteas
cleavag
site
fusion
tag
protein
interest
high
homogen
necessari
crystal
trial
requir
minim
nonspecif
variabl
cleavag
tag
remov
thrombin
enterokinas
enteropeptidas
factorxa
commonli
use
tag
remov
histor
shown
spuriou
cleavag
site
distinct
engin
site
contrast
viral
proteas
tobacco
etch
viru
tev
human
rhinoviru
proteas
lower
turnov
result
fewer
catalyt
event
suboptim
cleavag
site
thu
greater
specif
howev
lower
turnov
requir
larg
quantiti
proteas
requir
tag
remov
increas
cost
protein
product
particularli
multimilligram
scale
limit
remov
sumo
tag
sumo
proteas
provid
high
specif
high
effici
sumo
proteas
specif
recogn
tertiari
structur
sumo
tag
structur
found
elsewher
proteom
rather
linear
peptid
sequenc
cleav
precis
cterminu
tag
furthermor
sumo
proteas
k
cat
higher
tev
make
sumo
tagsumo
proteas
system
effici
costeffect
option
structur
work
grow
number
case
document
crystal
perform
intact
fusion
protein
review
smyth
moon
success
crystal
describ
fusion
mbp
gst
thioredoxin
lysozym
sumo
leav
fusion
tag
place
present
number
advantag
socal
carrierdriven
crystal
particularli
protein
interest
small
enough
occupi
avail
space
neighbor
tag
molecul
crystal
lattic
high
resolut
structur
mbp
gst
trx
sumo
determin
tag
provid
surfac
favor
crystal
lattic
format
extens
condit
crystal
tag
may
translat
condit
success
crystal
fusion
protein
addit
structur
tag
use
search
model
solv
crystallograph
phase
problem
molecular
replac
method
exampl
protein
structur
determin
without
tag
remov
shown
figur
gst
number
properti
make
good
candid
carrierdriven
crystal
gst
hydrophil
surfac
improv
solubl
protein
interest
gst
fusion
readili
purifi
via
glutathion
resin
final
structur
recombin
gst
known
sever
structur
small
peptid
protein
regulatori
domain
determin
gst
fusion
includ
hiv
ctermin
fibrinogen
gamma
chain
ankrynbind
domain
anak
atpas
acut
myelogen
nuclear
matrix
target
sequenc
amidomethylluciferin
aml
nmt
dna
replicationrel
elementbind
factor
set
protein
crystal
structur
report
presum
fuse
fragment
disord
success
carrierdriven
gst
appear
limit
date
protein
fragment
less
amino
acid
use
gst
present
ad
drawback
improv
solubl
case
form
dimer
lead
aggreg
certain
target
mbp
also
use
success
carrierdriven
crystal
like
gst
mbp
confer
increas
solubl
fusion
partner
crystal
structur
solv
addit
cterminu
mbp
form
solvent
access
ahelix
provid
rigid
support
link
protein
interest
although
mbp
provid
strategi
affin
purif
amylos
affin
chromatographi
mbpfusion
protein
often
fail
bind
amylos
resin
practic
furthermor
mbp
adopt
differ
conform
presenc
absenc
bound
maltos
partial
occup
maltos
lead
heterogen
final
product
detriment
crystal
format
addit
excess
maltos
may
requir
certain
purif
scheme
crystal
trial
circumv
issu
mbp
frequent
use
conjunct
purif
date
mbp
shown
highest
degre
success
carrier
protein
protein
structur
determin
structur
determin
mbp
fusion
design
short
rigid
linker
fusion
tag
protein
interest
critic
success
carrierdriven
crystal
varieti
linker
ntermin
truncat
target
protein
tri
linker
long
result
excess
flexibl
wherea
linker
short
may
influenc
target
protein
structur
addit
tag
incorpor
success
crystal
includ
thioredoxin
lysozym
sumo
lesser
extent
mbp
gst
like
mbp
cterminu
thioredoxin
end
rigid
solvent
access
ahelix
much
thioredoxin
polar
surfac
form
crystal
contact
thioredoxin
readili
crystal
despit
featur
two
crystal
one
solv
structur
report
use
thioredoxin
fusion
partner
rather
tradit
solubl
affin
tag
lysozym
use
replac
unstructur
loop
gprotein
coupl
receptor
lysozym
provid
increas
polar
surfac
conduc
lattic
format
multipl
structur
sumo
fusion
place
ncbi
structur
databas
sumo
fusion
tag
provid
interest
option
carrierdriven
crystal
discuss
sumo
improv
yield
solubl
across
wide
rang
target
structur
solv
high
resolut
importantli
sumo
star
system
amen
express
eukaryot
host
allow
product
protein
structur
studi
requir
express
eukaryot
host
produc
proper
fold
desir
eukaryot
posttransl
modif
tag
function
activ
need
gener
function
activ
protein
necess
mani
studi
especi
import
protein
question
potenti
therapeut
conform
characterist
includ
proper
fold
solubl
essenti
compon
function
activ
protein
improv
presenc
fusion
tag
howev
gener
nativ
nterminu
also
critic
function
activ
particularli
among
cytokin
small
peptid
cytotox
protein
present
addit
challeng
tag
use
cytokin
includ
interleukin
eg
interferon
eg
hifng
coloni
stimul
factor
gcsf
mcsf
gmcsf
hematopoiet
factor
erythropoeitin
thrombopoeitin
interest
immunomodulatori
effect
therapeut
potenti
rang
tag
use
express
cytokin
vari
level
success
gst
thioredoxin
perform
inconsist
solubil
type
protein
mbp
nusa
found
display
solubl
enhanc
properti
increas
express
level
target
protein
perhap
due
size
fact
nusa
use
success
express
purifi
cytokin
homolog
fold
remov
tag
requir
endoproteas
leav
addit
amino
acid
residu
nterminu
process
protein
affect
structur
andor
function
protein
tag
seen
consist
success
sumo
conformationspecif
activ
sumo
proteas
ensur
cleavag
occur
precis
nterminu
target
protein
sumo
shown
produc
array
function
activ
cytokin
express
high
level
use
sumo
biolog
activ
recent
ifng
gener
function
activ
form
follow
sumo
express
purif
although
express
inclus
bodi
previous
tnfa
also
gener
matur
activ
product
use
drug
develop
assay
final
activ
chemokin
drastic
alter
truncat
extens
nterminu
see
instanc
extens
studi
lu
et
al
use
sumotag
express
purifi
chemokin
activ
form
system
sumo
fusion
help
solubl
essenti
produc
protein
authent
nterminu
use
standard
sumotag
interest
variat
theme
use
tandem
fusion
thioredoxinsumo
promot
refold
chemokin
absenc
redox
buffer
antimicrobi
peptid
studi
role
physiolog
potenti
therapeut
main
peptid
famili
interest
defensin
cathelicidin
synthes
precursorprotein
proteolyt
cleav
produc
matur
peptid
precursor
protect
host
cell
cytotox
effect
matur
peptid
fusion
tag
use
mimic
precursor
prevent
cytotox
success
gener
function
peptid
similar
express
work
cytokin
tag
use
product
antimicrobi
peptid
encount
mix
result
see
review
li
gst
perform
inconsist
number
case
tag
fail
protect
proteolyt
cleavag
precursor
peptid
may
due
larg
size
gst
kda
especi
relat
small
antimicrobi
peptid
mbp
use
product
human
bdefensin
human
bdefensin
requir
refold
step
recov
fusion
protein
aggreg
purif
addit
tag
consist
success
express
antimicrobi
peptid
thioredoxin
use
achiev
highyield
precursor
peptid
cytoplasm
perhap
smaller
size
kda
sumo
also
small
size
kda
also
use
success
gener
defensin
cathelicidin
product
human
mg
per
l
ferment
obtain
purif
regard
cathelicidinderiv
antimicrobi
peptid
found
human
produc
conjunct
thioredoxin
dualtag
express
function
activ
protein
produc
sumo
includ
antibacteri
peptid
toxin
isol
spider
venom
antitumoranalges
peptid
purifi
scorpion
venom
use
selfsplic
tag
intein
purif
recombin
protein
first
describ
group
work
new
england
biolab
work
gave
rise
neb
impact
inteinmedi
purif
affin
chitinbind
tag
system
remain
frequent
use
intein
purif
methodolog
technolog
revolv
around
use
yeastderiv
protein
splice
element
coupl
bacteri
chitinbind
affin
purif
tag
express
protein
captur
chitin
column
wash
free
host
deriv
protein
releas
induct
cleavag
intein
mechanist
intein
spontan
undergo
sn
acyl
shift
ntermin
cystein
residu
form
thioester
bond
protein
interest
thioester
readili
cleav
number
small
molecul
acid
dtt
protein
interest
releas
thioester
small
molecul
depend
intend
use
use
carryout
ctermin
modif
simpli
hydrolyz
gener
ctermin
carboxyl
technolog
work
well
larg
number
protein
small
antibacteri
toxin
antibodi
fragment
human
cholin
acetyltransferas
becom
wide
use
method
gener
protein
purif
rather
found
widest
use
gener
protein
subsequ
use
ctermin
modif
via
thioester
gener
cleavag
includ
express
protein
ligat
nativ
chemic
ligat
techniqu
two
dispar
peptid
segment
join
togeth
ligat
ctermin
peptid
contain
ntermin
cystein
residu
ntermin
peptid
ctermin
thioester
attack
sulfhydryl
cystein
thioester
result
thioester
linkag
two
peptid
revers
intein
reaction
thioester
undergo
n
migrat
gener
standard
amid
bond
methodolog
frequent
use
introduc
nonnatur
amino
acid
protein
one
two
partner
produc
synthet
rather
biosynthet
one
interest
use
join
two
peptid
one
express
heavi
isotop
label
protein
c
n
produc
highli
refin
nmr
structur
two
protein
domain
identifi
extend
interact
interfac
two
protein
previous
thought
behav
independ
anoth
iter
methodolog
thioester
use
introduc
small
molecul
fluorophor
cterminu
protein
interest
gener
enzym
substrat
instanc
small
cottag
industri
grown
around
ctermin
modif
ubiquitin
ub
ubiquitinlik
protein
ubl
substratesinhibitor
ubldeconjug
enzym
deubiquitylas
desumoylas
deneddylas
etc
includ
inhibitor
ubaldehyd
ubvinylsulfon
among
other
substrat
ubamidomethylcoumarin
amc
ubrhodamin
ubaml
two
principl
disadvantag
intein
technolog
first
bind
capac
chitinagaros
low
typic
capac
chitinagaros
mg
recombin
proteinml
matrix
contrast
ni
imac
iexsepharos
column
capac
mgml
resin
consequ
one
must
use
rel
larg
column
insur
complet
captur
express
protein
gener
major
concern
laboratoryscal
decreas
desir
methodolog
manufactur
scale
second
cleavag
reaction
slow
column
cleavag
usual
carri
h
room
temperatur
day
c
long
incub
time
elev
temperatur
lead
increas
nonspecif
proteolysi
contamin
proteas
increas
risk
protein
denatur
final
use
high
level
reduc
agent
mm
detriment
recoveri
disulfid
link
protein
lead
subsequ
need
refold
overcom
disadvantag
wood
laboratori
princeton
activ
engag
modif
technolog
major
focu
replac
chitinbind
domain
type
purif
entiti
avoid
low
capac
chitinagaros
well
replac
column
chromatographi
mechan
method
primari
separ
see
review
banki
wood
briefli
new
method
either
requir
precipit
step
mediat
control
aggreg
elastinlik
polypeptid
tag
attach
intein
adsorpt
phasintag
intein
polyhydroxybutyr
nanogranul
produc
special
engin
strain
e
coli
none
method
tri
extens
outsid
origin
laboratori
separ
attempt
improv
purif
capac
intein
technolog
wang
et
al
ad
either
ubtag
sumotag
nterminu
intein
ctermin
target
protein
could
use
ni
imac
purif
induc
intein
cleavag
releas
protein
interest
without
use
proteas
ad
bonu
sumoand
ubtag
enhanc
express
level
compar
intein
alon
none
approach
address
issu
slow
cleavag
rate
tackl
problem
number
group
move
away
intein
use
proteas
part
fusion
tag
includ
tag
cystein
proteas
domain
vibrio
cholera
tag
catalyt
sortas
domain
staphylococcu
aureu
case
enzymat
cleavag
initi
oncolumn
addit
small
molecul
inositol
hexakisphosph
ca
respect
methodolog
gain
wide
accept
outsid
origin
laboratori
perhap
welldevelop
approach
develop
bryan
group
market
biorad
profin
system
instanc
affin
tag
prodomain
bacteri
enzym
subtilisin
engin
form
subtilisin
bind
high
affin
prodomain
coupl
agaros
affin
purif
two
proteas
tag
describ
cleavag
initi
small
molecul
case
fluorid
although
less
potent
enzym
activ
halid
ion
limit
use
buffer
anoth
drawback
selfcleav
system
requir
separ
express
purif
conjug
mutant
subtilisin
could
make
system
costprohibit
larg
scale
two
proteasebas
system
enzym
express
part
fusion
protein
insur
suffici
proteas
alway
present
larg
scale
protein
manufactur
often
quit
differ
small
scale
research
product
protein
product
research
develop
might
typic
involv
liter
cultur
less
obtain
desir
amount
purifi
product
commerci
product
often
requir
bioreactor
capabl
hold
sever
thousand
liter
challeng
high
quantiti
low
cost
bioprocess
mean
affin
fusion
tag
commonli
use
due
part
extra
time
cost
associ
tag
remov
subsequ
purif
step
larg
scale
therefor
tag
system
use
must
present
clear
advantag
product
therapeut
fcfusion
protein
bestknown
exampl
fusion
tag
use
larg
scale
manufactur
first
creat
potenti
aid
therapeut
sever
commerci
avail
drug
base
fcfusion
includ
belatacept
alefacept
organ
reject
abatacept
etanercept
rheumatoid
arthriti
fibercept
macular
degener
among
other
fcfusion
protein
consist
protein
interest
link
fc
domain
immunoglobulin
segment
heavi
chain
furthest
antigen
bind
site
amino
acid
size
fc
domain
attach
either
terminu
protein
interest
current
commerci
therapeut
use
fc
domain
human
although
option
iga
igm
current
explor
affin
tag
fc
domain
bind
high
affin
protein
surfac
protein
origin
isol
staphylococcu
aureu
often
bound
stationari
phase
resin
elut
accomplish
via
ph
gradient
commerci
deterg
combin
high
affin
simpl
elut
allow
fc
system
costeffect
scale
larg
enough
manufactur
purif
process
ancillari
benefit
addit
fc
domain
therapeut
compound
provid
fusion
sever
benefici
pharmacolog
properti
promin
addit
fc
domain
increas
serum
halflif
therapeut
increas
activ
accomplish
fc
domain
bind
neonat
fcreceptor
fcrn
play
role
protein
recycl
prevent
lysosom
degrad
fc
domain
also
interact
fcreceptor
present
certain
cell
immun
system
blymphocyt
natur
killer
cell
abil
import
certain
type
oncolog
therapeut
final
addit
fc
domain
improv
solubl
overal
fusion
due
fact
fold
independ
fusion
partner
sinc
fcdomain
essenti
function
section
final
therapeut
cleavag
step
necessari
order
afus
system
undergo
tag
remov
consid
larger
scale
protein
express
addit
benefit
must
present
offset
addit
purif
cost
one
system
sumo
previous
mention
sumo
increas
yield
solubl
fusion
partner
cleavag
tag
perform
specif
sumo
proteas
leav
addit
amino
acid
behind
disrupt
therapeut
function
combin
affin
tag
sumo
tag
proteas
simpl
purif
scheme
base
imac
chromatographi
use
current
sumo
tag
use
sever
express
system
includ
e
coli
pichia
pastori
mammalian
cell
hek
cho
recent
exampl
includ
product
antivir
protein
cyanovirinn
cvn
microbicid
antihiv
effect
express
cvn
sumo
tag
lead
solubl
protein
level
e
coli
total
solubl
protein
use
l
bioreactor
addit
sumo
use
product
subunit
antigen
anthrax
swine
flu
test
sponsor
darpa
requir
rapid
antigen
product
costperdos
threshold
l
scale
maximum
product
output
gl
costperdos
well
requir
